Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia.Heart Lung Circ. 2020 Aug; 29(8):1109-1111.HL
Links
MeSH
Pub Type(s)
Editorial
Language
eng
PubMed ID
32653299
Citation
Adikari, Dona H., et al. "Collateral Damage: the Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia." Heart, Lung & Circulation, vol. 29, no. 8, 2020, pp. 1109-1111.
Adikari DH, Kushwaha VV, Jepson NS. Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia. Heart Lung Circ. 2020;29(8):1109-1111.
Adikari, D. H., Kushwaha, V. V., & Jepson, N. S. (2020). Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia. Heart, Lung & Circulation, 29(8), 1109-1111. https://doi.org/10.1016/j.hlc.2020.06.008
Adikari DH, Kushwaha VV, Jepson NS. Collateral Damage: the Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia. Heart Lung Circ. 2020;29(8):1109-1111. PubMed PMID: 32653299.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Collateral Damage: The Cardiovascular Cost of Suppressing COVID-19 Transmission in Australia.
AU - Adikari,Dona H,
AU - Kushwaha,Virag V,
AU - Jepson,Nigel S,
Y1 - 2020/07/01/
PY - 2020/06/09/received
PY - 2020/06/13/revised
PY - 2020/06/21/accepted
PY - 2020/7/13/pubmed
PY - 2020/9/4/medline
PY - 2020/7/13/entrez
KW - Cardiovascular disease
KW - Myocardial infarction
SP - 1109
EP - 1111
JF - Heart, lung & circulation
JO - Heart Lung Circ
VL - 29
IS - 8
SN - 1444-2892
UR - https://www.unboundmedicine.com/medline/citation/32653299/Collateral_Damage:_The_Cardiovascular_Cost_of_Suppressing_COVID_19_Transmission_in_Australia_
DB - PRIME
DP - Unbound Medicine
ER -